Methoxy Polyethylene Glycol-Epoetin Beta Generics Suppliers & Bulk Manufacturers
Available Forms: Solution for Injection
Available Strengths: 25–250 mcg
Reference Brands: Mircera® (US &EU)
Category: Nephrology
Methoxy Polyethylene Glycol-Epoetin Beta Generics is available in Solution for Injection and strengths such as 25–250 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Methoxy Polyethylene Glycol-Epoetin Beta Generics is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Methoxy Polyethylene Glycol-Epoetin Beta Generics can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description:
Methoxy Polyethylene Glycol-Epoetin Beta, branded as Mircera®, is an advanced erythropoiesis-stimulating agent (ESA) designed for the treatment of anemia in chronic kidney disease (CKD) patients. Its long half-life enables once-monthly or biweekly dosing, improving compliance and reducing injection frequency. Approved in both the EU and US, Mircera® is widely used in dialysis and non-dialysis CKD populations. Available as prefilled syringes and vials in multiple strengths, it is an essential product in nephrology care. A strategic asset for pharmaceutical B2B partners, it offers opportunities in licensing, distribution, and hospital tenders across regulated markets with growing CKD treatment needs.
Frequently Asked Questions
Related Products
Calcitriol
Strength: Capsules:0.25 mcg, 0.5 mcg; Injection:1 mcg/mL
Form: Capsules & Injection
Reference Brands: Rocaltrol®(EU & US), Calcijex® (US)
View Details
Paricalcitol Generics
Strength: Capsules:1mcg, 2mcg, 4 mcg & Injection: 2mcg/mL , 5mcg/mL
Form: Capsules and Injection
Reference Brands: Zemplar®(US &EU)
View Details
Sodium Zirconium Cyclosilicate Generics
Strength: 5g, 7g,10g sachets
Form: Powder for oral suspension
Reference Brands: Lokelma® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers